Boeing Decision Underscores Need for Board Oversight of “Mission Critical” Product Safety Risks – And Documentation Demonstrating This Oversight
Posted on:
Featured, Insights, Latest Thinking, Securities Litigation, Enforcement & Investigations, What's NewThe Delaware Court of Chancery’s recent decision denying a motion to dismiss in In re The Boeing Company Derivative Litigation serves as a reminder to directors and their counsellors of the importance of board and board committee level oversight and monitoring of “mission critical” product safety risks – as well as the importance of documenting these efforts in a manner that can be produced to stockholders making demands for books and records. In this Securities Litigation Alert, we discuss the litigation ramifications of this decision, particularly in regards to Section 220 of the Delaware General Corporation Law.
Please click here to read the alert.
Contributor(s)
More from the Governance & Securities Watch
Copyright © 2024 Weil, Gotshal & Manges LLP, All Rights Reserved. The contents of this website may contain attorney advertising under the laws of various states. Prior results do not guarantee a similar outcome. Weil, Gotshal & Manges LLP is headquartered in New York and has office locations in Boston, Brussels, Dallas, Frankfurt, Hong Kong, Houston, London, Miami, Munich, New York, Paris, Shanghai, Silicon Valley and Washington, D.C.